SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-025079
Filing Date
2020-02-26
Accepted
2020-02-26 09:00:43
Documents
4
Period of Report
2020-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2010842d1_8k.htm 8-K 19938
2 EXHIBIT 99.1 tm2010842d1_ex99-1.htm EX-99.1 12934
3 EXHIBIT 99.2 tm2010842d1_ex99-2.htm EX-99.2 8953
4 GRAPHIC slide01.jpg GRAPHIC 537776
  Complete submission text file 0001104659-20-025079.txt   783927
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 20653423
SIC: 2834 Pharmaceutical Preparations